198 related articles for article (PubMed ID: 31517670)
1. On the Relation Between G-formula and Inverse Probability Weighting Estimators for Generalizing Trial Results.
Dahabreh IJ; Robertson SE; Hernán MA
Epidemiology; 2019 Nov; 30(6):807-812. PubMed ID: 31517670
[TBL] [Abstract][Full Text] [Related]
2. Nonparametric inverse-probability-weighted estimators based on the highly adaptive lasso.
Ertefaie A; Hejazi NS; van der Laan MJ
Biometrics; 2023 Jun; 79(2):1029-1041. PubMed ID: 35839293
[TBL] [Abstract][Full Text] [Related]
3. Doubly robust inference for targeted minimum loss-based estimation in randomized trials with missing outcome data.
Díaz I; van der Laan MJ
Stat Med; 2017 Oct; 36(24):3807-3819. PubMed ID: 28744883
[TBL] [Abstract][Full Text] [Related]
4. Model misspecification and bias for inverse probability weighting estimators of average causal effects.
Waernbaum I; Pazzagli L
Biom J; 2023 Feb; 65(2):e2100118. PubMed ID: 36045099
[TBL] [Abstract][Full Text] [Related]
5. Efficiency and robustness of causal effect estimators when noncompliance is measured with error.
Boatman JA; Vock DM; Koopmeiners JS
Stat Med; 2018 Dec; 37(28):4126-4141. PubMed ID: 30109713
[TBL] [Abstract][Full Text] [Related]
6. Machine Learning for Causal Inference: On the Use of Cross-fit Estimators.
Zivich PN; Breskin A
Epidemiology; 2021 May; 32(3):393-401. PubMed ID: 33591058
[TBL] [Abstract][Full Text] [Related]
7. Model misspecification and robustness in causal inference: comparing matching with doubly robust estimation.
Waernbaum I
Stat Med; 2012 Jul; 31(15):1572-81. PubMed ID: 22359267
[TBL] [Abstract][Full Text] [Related]
8. Generalizing trial evidence to target populations in non-nested designs: Applications to AIDS clinical trials.
Li F; Buchanan AL; Cole SR
J R Stat Soc Ser C Appl Stat; 2022 Jun; 71(3):669-697. PubMed ID: 35968541
[TBL] [Abstract][Full Text] [Related]
9. Study Designs for Extending Causal Inferences From a Randomized Trial to a Target Population.
Dahabreh IJ; Haneuse SJA; Robins JM; Robertson SE; Buchanan AL; Stuart EA; Hernán MA
Am J Epidemiol; 2021 Aug; 190(8):1632-1642. PubMed ID: 33324969
[TBL] [Abstract][Full Text] [Related]
10. Doubly robust estimators for generalizing treatment effects on survival outcomes from randomized controlled trials to a target population.
Lee D; Yang S; Wang X
J Causal Inference; 2022; 10(1):415-440. PubMed ID: 37637433
[TBL] [Abstract][Full Text] [Related]
11. Improving causal inference with a doubly robust estimator that combines propensity score stratification and weighting.
Linden A
J Eval Clin Pract; 2017 Aug; 23(4):697-702. PubMed ID: 28116816
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the time-varying Cox model for the cause-specific hazard functions with missing causes.
Heng F; Sun Y; Hyun S; Gilbert PB
Lifetime Data Anal; 2020 Oct; 26(4):731-760. PubMed ID: 32274677
[TBL] [Abstract][Full Text] [Related]
13. G-computation and doubly robust standardisation for continuous-time data: A comparison with inverse probability weighting.
Chatton A; Borgne FL; Leyrat C; Foucher Y
Stat Methods Med Res; 2022 Apr; 31(4):706-718. PubMed ID: 34861799
[TBL] [Abstract][Full Text] [Related]
14. Decreased Susceptibility of Marginal Odds Ratios to Finite-sample Bias.
Ross RK; Cole SR; Richardson DB
Epidemiology; 2021 Sep; 32(5):648-652. PubMed ID: 34001751
[TBL] [Abstract][Full Text] [Related]
15. Improving trial generalizability using observational studies.
Lee D; Yang S; Dong L; Wang X; Zeng D; Cai J
Biometrics; 2023 Jun; 79(2):1213-1225. PubMed ID: 34862966
[TBL] [Abstract][Full Text] [Related]
16. Inverse probability of treatment weighting with generalized linear outcome models for doubly robust estimation.
Gabriel EE; Sachs MC; Martinussen T; Waernbaum I; Goetghebeur E; Vansteelandt S; Sjölander A
Stat Med; 2024 Feb; 43(3):534-547. PubMed ID: 38096856
[TBL] [Abstract][Full Text] [Related]
17. Impact of outcome model misspecification on regression and doubly-robust inverse probability weighting to estimate causal effect.
Lefebvre G; Gustafson P
Int J Biostat; 2010; 6(2):Article 15. PubMed ID: 21969999
[TBL] [Abstract][Full Text] [Related]
18. Comparing Parametric, Nonparametric, and Semiparametric Estimators: The Weibull Trials.
Cole SR; Edwards JK; Breskin A; Hudgens MG
Am J Epidemiol; 2021 Aug; 190(8):1643-1651. PubMed ID: 33569578
[TBL] [Abstract][Full Text] [Related]
19. MULTIPLY ROBUST ESTIMATORS OF CAUSAL EFFECTS FOR SURVIVAL OUTCOMES.
Wen L; Hernán MA; Robins JM
Scand Stat Theory Appl; 2022 Sep; 49(3):1304-1328. PubMed ID: 36033967
[TBL] [Abstract][Full Text] [Related]
20. Augmented and doubly robust G-estimation of causal effects under a Structural nested failure time model.
Mertens K; Vansteelandt S
Biometrics; 2018 Jun; 74(2):472-480. PubMed ID: 28742252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
